| 000 | 01518 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513234846.0 | ||
| 264 | 0 | _c20010719 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M100938200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKeifer, J A | |
| 245 | 0 | 0 |
_aInhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cJun 2001 |
||
| 300 |
_a22382-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aDNA Probes |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aI-kappa B Kinase |
| 650 | 0 | 4 |
_aInterleukin-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInterleukin-8 _xgenetics |
| 650 | 0 | 4 | _aJurkat Cells |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThalidomide _xpharmacology |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aGuttridge, D C | |
| 700 | 1 | _aAshburner, B P | |
| 700 | 1 | _aBaldwin, A S | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 276 _gno. 25 _gp. 22382-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M100938200 _zAvailable from publisher's website |
| 999 |
_c11232617 _d11232617 |
||